Patients with wild-type transthyretin cardiac amyloidosis (ATTRwt)
Clinicians must recognize the broad and atypical clinical spectrum of ATTRwt to correctly identify patients for emerging disease-modifying treatments.
The clinical spectrum of ATTRwt is heterogeneous and differs from the classic phenotype: women are affected in a significant proportion; asymmetric LV hypertrophy and impaired LVEF are not rare and only a minority have low QRS voltages. Clinicians should be aware of the broad clinical spectrum of ATTRwt to correctly identify an entity for which a number of disease-modifying treatments are under investigation.
Building similarity graph...
Analyzing shared references across papers
Loading...
Esther González-López
Christian Gagliardi
Fernándo Domínguez
European Heart Journal
University of Bologna
Centro de Investigación Biomédica en Red
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Building similarity graph...
Analyzing shared references across papers
Loading...
González-López et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69d5719075589c71d767e31e — DOI: https://doi.org/10.1093/eurheartj/ehx043